Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor-selective viral replication leverages the altered transcriptional landscape, surface marker expression, metabolic changes, and immune evasion characteristics of malignant versus healthy tissue. This approach ensures that the cytolytic effects—and any delivered therapeutic transgenes—are focused on neoplastic lesions while minimizing off-target toxicity.
Selective viral replication and lysis of tumor cells, induction of immunogenic cell death.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Cell (Selective Viral Replication) (N/A).